4//SEC Filing
Kanes Stephen 4
Accession 0001847903-25-000028
CIK 0001847903other
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 4:57 PM ET
Size
5.9 KB
Accession
0001847903-25-000028
Insider Transaction Report
Form 4
Kanes Stephen
Chief Medical Officer
Transactions
- Award
Share Option (right to buy)
2025-02-03+500,000→ 500,000 totalExercise: $16.90Exp: 2035-02-03→ Ordinary Shares (500,000 underlying)
Footnotes (2)
- [F1]25% of the shares subject to such option shall vest and become exercisable on February 3, 2026 and the remaining 75% of the shares subject to such option shall vest and become exercisable in 36 monthly installments thereafter.
- [F2]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
Documents
Issuer
Centessa Pharmaceuticals plc
CIK 0001847903
Entity typeother
Related Parties
1- filerCIK 0001612859
Filing Metadata
- Form type
- 4
- Filed
- Feb 3, 7:00 PM ET
- Accepted
- Feb 4, 4:57 PM ET
- Size
- 5.9 KB